New Electrochemical detection software enables full CFR21 Part11 compliance ...

ESA Biosciences, Inc., a subsidiary of Magellan Biosciences, Inc., has announced new Version 3.0 application software designed to further increase the operational effectiveness of its highly sensitive and selective CoulArray® HPLC electrochemical array detector.

The new, streamlined software features single window interface operating controls and enables the CoulArray detector to effectively handle ballistic (< 5 min) gradient conditions when higher throughput LC assays require many samples to be processed in a short period of time. In addition, the Version 3.0 software enables full CFR21 Part II compliance permitting the CoulArray detector to operate in regulated drug development laboratories.

The enhanced ESA software comes with complete security features, audit trails, electronic signatures and data traceability. Its easy-to-use wizards, PDF report generation capabilities and compatibility with Windows 2000/XP operating systems make Version 3.0 the latest and most advanced software package for CoulArray users.

ESA's CoulArray Detector is a state-of-the-art electrochemical detection system for more demanding clinical, life science and pharmaceutical applications and is widely recognised as the benchmark electrochemical detector for many assays. The Version 3.0 software enables the CoulArray to be used more effectively and efficiently in a wide range of fields, especially in pharmaceutical discovery and development.

ESA Biosciences Inc, is a leading manufacturer and supplier of analytical instruments for the life science, clinical diagnostic, drug discovery and pharmaceutical industries. Founded in 1968, ESA offers a complete line of HPLC systems, components, and advanced detectors, along with a broad range of analytical services.